Call toll free: 0307 472 1942

Search

Publications 2016

January 2016

  1. Baan CC, Bromberg JS, Chapman JR, Geissler EK, Pomfret EA,   Tullius SG. Transplantation Reaches 100th Volume. Transplantation. 2016;100(1):1. Jan. DOI: 10.1097/01.TP.0000475956.36941.e6

  2. Chan S, Fahim MA, Macdonald GA, Johnson DW. Treatment of hepatitis B in patients with chronic kidney disease. In: Hepatitis B treatment, Avid Science, Berlin, Germany, 2016.

  3. Cho Y, Johnson DW, Vesey DA, Hawley CM, Pascoe EM, Clarke M, Topley, N. Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction. Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis. 2016;36(1):16-25. Jan-Feb. DOI: 10.3747/pdi.2013.002743.

  4. Howell M, Wong G, Rose J, Tong A, Craig JC, Howard K. Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: a pilot best-worst scaling survey. BMJ Open. 2016;6(1):e008163. Jan 27. DOI: 10.1136/bmjopen-2015-0081634.

  5. Mahmood U, Cho Y, Johnson DW. Peritoneal dialysis solutions. In: Ekart R (ed.), Peritoneal dialysis, InTech, Rijeka, Croatia, 2016.

  6. Ma MK, Lim WH, Craig JC, Russ GR, Chapman JR, Wong G. Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors. Clinical Journal of the American Society of Nephrology. 2016;11(1):128-36. Jan 7. DOI: 10.2215/CJN.037604155.

  7. Mudge DW, Boudville N, Brown F, Clayton P, Duddington M, Holt S, Johnson DW, Jose M, Sawiers W, Sud K, Voss D, Walker R. Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the action. Nephrology. 2016. Jan 25. DOI: 10.1111/nep.12731.

  8. Nadeau-Fredette AC, Johnson DW, Hawley CM, Pascoe EM, Cho Y, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP. Centre-specific factors associated with peritonitis risk-A multi-center registry analysis. Peritoneal Dialysis International. 2016. Jan 13. DOI:10.3747/pdi.2015.001467.

  9. Nataatmadja M, Cho Y, Fahim M, Johnson DW. Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease: An Update. Reviews on Recent Clinical Trials. 2016;11(1):12-32. Jan.8.

  10. Ralph AF, Alyami A, Allen RD, Howard K, Craig JC, Chadban SJ, Irving M, Tong A. Attitudes and beliefs about deceased organ donation in the Arabic-speaking community in Australia: a focus group study. BMJ open. 2016;6(1):e010138. Jan 21. DOI:10.1136/bmjopen-2015-0101389.

  11. See E, Hawley CM, Agar J, Johnson DW. Fluid convection, generation and reinfusion in haemodiafiltraton. In: Karkar A (ed.), Advances in Hemodiafiltration, InTech, Rijeka, Croatia, 2016.

  12. Taylor MJ, Hanson CS, Casey JR, Craig JC, Harris D, Tong A. “You know your own fistula, it becomes a part of you”-Patient perspectives on vascular access: A semistructured interview study.Hemodialysis International. 2016;20(1):5-14. Jan. DOI: 10.1111/hdi.12340

February 2016

  1. Brown DP, Chapman JR. Care of Transplant Recipients in Primary Practice. Transplantation.   2016;100(3):474-6. Feb 24. DOI: 10.1097/TP.0000000000001139

  2. Hanson CS, Chadban SJ, Chapman JR, Craig JC, Wong G, Tong A. Nephrologists’ Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation. Transplantation. 2016;100(4):943-53. Feb 10. DOI: 10.1097/tp.0000000000000921

  3. Joseph PD, Caldwell PH, Tong A, Hanson CS, Craig JC. Stakeholder Views of Clinical Trials in Low- and Middle-Income Countries: A Systematic Review. Pediatrics. 2016;137(2):1-19. Feb. DOI:10.1542/peds.2015-2800

  4. Krishnasamy R, Hawley CM, Stanton T, Howden EJ, Beetham KS, Strand H, Leano R, Haluska BA, Coombes JS, Isbel NM. Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction. Nephrology 2016 (DOI: 10.1111/nep.12557).

  5. Lim WH, McDonald SP, Coates PT, Chapman JR, Russ GR, Wong G. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation. Kidney International. 2016;89(3):659-65. Feb 18. DOI: 10.1016/j.kint.2015.11.016

  6. O’Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, Parker D, Whiteley W, Strippoli GF, Palmer SC, Craig JC, Webster AC. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2016 Feb 23. DOI: 10.1053/j.ajkd.2015.12.028

  7. Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Schon S, Gargano L, Bots CP, Strippoli GFM. Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis. Nephrology Dialysis Transplantation 2016; 0:1-7

  8. Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto CC, McWhinney BC, Ungerer JP, Campbell KL. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. Clinical Journal of the American Society of Nephrology. 2016;11(2):223-31. Feb 5. DOI: 10.2215/CJN.0524051

  9. Tong A, Tunnicliffe DJ, Lopez-Vargas P, Mallett A, Patel C, Savige J, Campbell K, Patel M, Tchan MC, Alexander SI, Lee V, Craig JC, Fassett R, Rangan GK. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology 2016;21(2):122-32. Feb. DOI: 10.1111/nep.12579

  10. Zhang L, Hawley CM, Johnson DW. Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrology, Dialysis, Transplantation. 2016;31(2):214-22. Feb 26. DOI: 10.1093/ndt/gfu403

March 2016

  1. Briskey D, Tucker P, Johnson DW, Coombes JS. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology. 2016 (DOI10.1007/s10157-016-1255-y)

  2. Brown DP, Chapman JR. Care of Transplant Recipients in Primary Practice. Transplantation. 2016;100(3):474-6. (DOI 10.1097/tp.0000000000001139)

  3. Chapman JR, Delmonico FL. Buyer beware transplantation. Kidney Int. 2016;89(5):983-5. (DOI 10.1016/j.kint.2016.01.021)

  4. Cho Y, Buchel J, Steppan S, Passlick-Deetjen J, Hawley CM, Dimeski G, Clarke M, Johnson DW. Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions. Peritoneal Dialysis International 2016; 36(2): 146-153. (DOI: 10.3747/pdi.2014.00291)

  5. Ellis RJ, Small DM, Vesey DA, Johnson DW, Francis R, Vitetta L, Gobe GC, Morais C. Indoxyl sulphate and kidney disease: Causes, consequences and interventions. Nephrology 2016;21(3):170-7. (DOI10.1111/nep.12580)

  6. Jamieson NJ, Hanson CS, Josephson MA, Gordon EJ, Craig JC, Halleck F, Budde K, Tong A. Motivations, Challenges, and Attitudes to Self-management in Kidney Transplant Recipients: A Systematic Review of Qualitative Studies. American Journal of Kidney Diseases 2016;67(3):461-78. (DOI 10.1053/j.ajkd.2015.07.030)

  7. Lim WH, McDonald SP, Coates PT, Chapman JR, Russ GR, Wong G. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation. Kidney Int. 2016;89(3):659-65. (DOI 10.1016/j.kint.2015.11.016)

  8. Lopez-Vargas PA, Tong A, Howell M, Craig JC. Educational Interventions for Patients With CKD: A Systematic Review. American Journal of Kidney Diseases 2016. (DOI 10.1053/j.ajkd.2016.01.022)

  9. Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, Schick-Makaroff K,Wheeler DC,van Biesen W, Winkelmayer WC, Johnson DW, Howard K, Evangelidis N, Tong A. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. American Journal of Kidney Diseases 2016. (DOI 10.1053/j.ajkd.2016.02.037)

  10. Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi SL, Ong ML, Irish AB. Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology 2016;21(3):217-28. (DOI 10.1111/nep.12573)

April 2016

  1. Badve SV, Palmer SC, Strippoli GF, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath S S, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW. The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2016. (DOI 10.1053/j.ajkd.2016.03.418)

  2. Caldwell PH, Sureshkumar P, Kerr MI, Hamilton S, Teixeira-Pinto A, Macaskill P, Craig JC. A randomised controlled trial of a code-word enuresis alarm. Archives of Disease in Childhood. 2016;101(4):326-31. (DOI 10.1136/archdischild-2015-308564)

  3. Campbell DJ, Brown FG, Craig JC, Gallagher MP, Johnson DW, Kirkland GS, Kumar SK, Lim WH, Ranganathan D, Saweirs W, Sud K, Toussaint ND, Walker RG, Williams LA, Yehia M, Mudge DW. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrology, Dialysis, Transplantation. 2016;31(4):619-27. (DOI 10.1093/ndt/gfv115)

  4. Chapman JR, Delmonico FL. Buyer beware transplantation. Kidney Int. 2016;89(5):983-5. (DOI 10.1016/j.kint.2016.01.021)

  5. Clayton PA, Saunders JR, McDonald SP, Allen RD, Pilmore H, Saunder A, Boudville N, Chadban SJ. Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012. Transplantation 2016;100(6):1278-83. (DOI10.1097/tp.0000000000000877)

  6. Fahim MA, Hayen AD, Horvath AR, Dimeski G, Coburn A, Tan KS, Johnson DW, Craig JC, Campbell SB, Hawley CM. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clinical chemistry and laboratory medicine. 2016;54(5):e149-50. (DOI 10.1515/cclm-2015-0998)

  7. Gobe GC, Ng KL, Small DM, Vesey DA, Johnson DW, Samaratunga H, Oliver K, Wood S, Barclay JL, Rajandram R, Li L, Morais C. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways. Biochemical and Biophysical Research Communications. 2016;473(1):47-53. (DOI 10.1016/j.bbrc.2016.03.048)

  8. Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P. Association between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Nephrology 2016. (DOI 10.1111/nep.12815)

  9. Hanson CS, Chadban SJ, Chapman JR, Craig JC, Wong G, Tong A. Nephrologists’ Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation. Transplantation. 2016;100(4):943-53. (DOI 10.1097/tp.0000000000000921)

  10. Hoy WE, Mott SA, McDonald SP. An expanded nationwide view of chronic kidney disease in Aboriginal Australians. Nephrology 2016. (DOI 10.1111/nep.12798)

  11. Krishnan AR, Wong G, Chapman JR, Coates PT, Russ GR, Pleass H, Russell C, He B, Lim WH. Prolonged Ischemic Time, Delayed Graft Function, Graft and Patient Outcomes in Live-Donor Kidney Transplant Recipients. American Journal of Transplantation 2016. (DOI 10.1111/ajt.13817)

  12. Lan PG, Clayton PA, Johnson DW, McDonald SP, Borlace M, Sud K, Badve SV, Boudville N. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure. Peritoneal Dialysis International 2016. (DOI 10.3747/pdi.2015.00218)

  13. Lim WH, Chapman JR, Coates PT, Lewis JR, Russ GR, Watson N, Holdsworth R, Wong G. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology 2016;11(5):875-83. (DOI 10.2215/cjn.11641115)

  14. Lo P, Sharma A, Craig JC, Wyburn K, Lim W, Chapman JR, Palmer SC, Strippoli GF, Wong G. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis. Transplantation 2016;100(4):933-42. (DOI 10.1097/tp.0000000000000933)

  15. Marshall MR, Polkinghorne KR, Kerr PG, Hawley CM, Agar JW, McDonald SP. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations. American Journal of Kidney Diseases 2016;67(4):617-28. (DOI 10.1053/j.ajkd.2015.09.025)

  16. Nadeau-Fredette AC, Johnson DW. Opponent’s comments. Nephrology, Dialysis, Transplantation. 2016;31(4):524. (DOI 10.1093/ndt/gfw031a)

  17. Nadeau-Fredette AC, Johnson DW. Con: Buttonhole cannulation of arteriovenous fistulae. Nephrology, Dialysis, Transplantation 2016;31(4):525-8.(DOI 10.1093/ndt/gfw030)

  18. Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Isbel NM, Krum H, Pascoe EM, Perkovic V, Scaria A, Tonkin AM, Vergara LA, Hawley CM. The beta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial. American Journal of Kidney Diseases 2016;67(6):902-11. (DOI 10.1053/j.ajkd.2015.10.029)

  19. Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB. Updates on Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology 2016. (DOI 10.1111/nep.12823)

  20. Young C, Tong A, Sherriff S, Kalucy D, Fernando P, Muthayya S, Craig JC. Building better research partnerships by understanding how Aboriginal health communities perceive and use data: a semistructured interview study. BMJ Open. 2016;6(4):e010792. (DOI 10.1136/bmjopen-2015-010792)

  21. Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney Int. 2016;89(6):1337-45. (DOI 10.1016/j.kint.2016.02.014)

  22. Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh C A, Polkinghorne KR, Johnson DW. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study. Nephrology 2016;21(5):387-96. (DOI 10.1111/nep.12629)

May 2016

  1. Boonprasert K, Vesey DA, Gobe GC, Moore MR, Ruenweerayut R, Johnson DW, Na-Bangchang K, Satarug S. The stress response of human proximal tubules cells to cadmium involves up-regulation of haemoxygenase-1 and metallothionein but not cytochrome P450 enzymes. Toxicology Letters 2016; 249: 5-14.

  2. Howard K, Jan S, Rose JM, Wong G, Craig JC, Irving M, Tong A, Chadban S, Allen RD, Cass A. Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment. Transplantation 2016;100(5):1136-48 (DOI: 10.1097/TP.0000000000000940)

  3. Howell M, Wong G, Turner RM, Tan HT, Tong A, Craig JC, Howard K. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2016;67(5):762-74 (DOI: 10.1053/j.ajkd.2015.11.006)

  4. Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation 2016 (DOI: 10.1093 /ndt/gfw075)

  5. Mahady SE, Gale J, Macaskill P, Craig JC, George J. Prevalence of elevated alanine transaminase (ALT) in Australia and its relationship to metabolic risk factors: a cross sectional study of 9,447 people. Journal of Gastroenterology and Hepatology 2016 (DOI: 10.1111 /jgh.13434)

  6. Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O’Neill S, Craig JC, Tong A. Patients’ Perspectives and Experiences Living with Systemic Sclerosis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Journal of Gastroenterology and Hepatology 2016;43(7):1363-75 (DOI: 10.1111/ jgh.13434 10.3899/jrheum.151309)

  7. Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GF. Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. The Cochrane Database of Systematic Reviews 2016(5):Cd004541 (DOI: 10.1002/14651858.CD004541.pub3)

  8. Perl J, Davies SJ, Lambie M, Pisoni RL, McCullough K, Johnson DW, Sloand JA, Prichard S, Kawanishi H, Tentori F, Robinson BM. The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Unifying Efforts to Inform Practice and Improve Global Outcomes in Peritoneal Dialysis. Peritoneal Dialysis International 2016;36(3):297-307 (DOI: 10.3747/pdi.2014.00288)

  9. Tong A, Craig JC. Tuning into Qualitative Research-A Channel for the Patient Voice. Clinical Journal of the American Society of Nephrology 2016 (DOI: 10.2215/cjn.05110516)

  10. Torres VE, Higashihara E, Devuyst O, Chapman AB, Gansevoort RT, Grantham JJ, Perrone RD, Ouyang J, Blais JD, Czerwiec FS for the TEMPO 3:4 Trial Investigators. Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial. Clinical Journal of the American Society of Nephrology 2016; 11(5): 803-11.

June 2016

  1. Cai TY, Magnussen C, Haluska B, Johnson DW, Mottram PM, Isbel N, Celermajer DS, Marwick TH, Skilton MR. Carotid extra-medial thickness does not predict adverse cardiovascular outcomes in high-risk adults. Diabetes Metabolism 2016; 42(3): 200-203. (DOI: 10.1016/j.diabet.2015.12.001)

  2. Francis A, Didsbury M, Lim WH, Kim S, White S, Craig JC, Wong G. The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children. Pediatric Nephrology 2016; 31(6): 1011-1019. (DOI: 10.1007/s00467-015-3279-z)

  3. Hanson CS, Chapman JR, Craig JC, Harris DC, Kairaitis LK, Nicdao M, Mikaheal M, Tong A. Patient experiences of training and transition to home haemodialysis: A mixed-methods study. Nephrology 2016; (DOI: 10.1111/nep.12827)

  4. Kim S, Macaskill P, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC. Beginning the trajectory to ESKD in adult life: Albuminuria in Australian aboriginal children and adolescents. Pediatric Nephrology 2016; (DOI: 10.1007/s00467-016-3429-y)

  5. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Peritoneal Dialysis International 2016. (DOI: 10.3747/pdi.2016.00078)

  6. Lopez-Vargas P A, Tong A, Howell M, Phoon RK, Chadban SJ, Shen Y, Craig JC. Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease – a mixed-methods study. Nephrology 2016 (DOI: 10.1111/nep.12829)

  7. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. Journal of the American Society of Nephrology 2016. (DOI: 10.1681/asn.2016010112)

  8. Mudge DW, Webster AC, Johnson DW . Pro: Meta-analysis: The case for. Nephrology Dialysis and Transplant 2016; 31(6): 875-880. (DOI: 10.1093/ndt/gfw091)

  9. Tong A, Budde K, Gill J, Josephson MA, Marson L, Pruett TL, Reese PP, Rosenbloom D, Rostaing L, Warrens AN, Wong G, Craig JC, Crowe S, Harris T, Hemmelgarn B, Manns B, Tugwell P, Van Biesen W, Wheeler DC, Winkelmayer WC, Evangelidis N, Sautenet B, Howell M, Chapman JR. Standardized outcomes in nephrology-transplantation: A global initiative to develop a core outcome set for trials in kidney transplantation. Transplant Direct 2016; 2(6): e79. (DOI: 10.1097/txd.0000000000000593)

  10. Tong A, Palmer S, Craig JC, Strippoli GF. A guide to reading and using systematic reviews of qualitative research. Nephrology Dialysis Transplantation 2016; 31(6): 897-903. (DOI: 10.1093/ndt/gfu354)

  11. Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW,O’Neill SG, Ralph AF, Craig JC, Tong A. Lupus means sacrifices: Perspectives of adolescents and young adults with systemic lupus erythematosus. Arthritis Care Research 2016; 68(6): 828-837. (DOI: 10.1002/acr.22749)

  12. Young V, Balaam S, Orazio L, Bates A, Badve SV, Johnson DW, Campbell KL. Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis. Journal of Renal Care,2016; 42(2): 123-131. (DOI: 10.1111/jorc.12156)

July 2016

  1. Badve SV, Pascoe E M, Burke M, Clayton PA, Campbell SB, Hawley CM,Lim WH, McDonald SP, Wong G, Johnson DW. Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients. Clinical Journal of the American Society of Nephrology 2016. (DOI: 10.2215/cjn.00190116)

  2. Briskey D, Tucker PS, Johnson DW, Coombes JS. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD. Nitric Oxide 2016; 57: 64-70. (DOI: 10.1016/j.niox.2016.05.002)

  3. Davis E, Campbell K, Gobe G, Hawley C, Isbel N, Johnson DW. Association of anthropometric measures with kidney disease progression and mortality: A retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service. BMC Nephrology 2016; 17(1): 74. (DOI: 10.1186/s12882-016-0290-y)

  4. Kim S, Macaskill P, Baur LA, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig, JC. The differential effect of socio-economic status, birth weight and gender on body mass index in Australian aboriginal children. International Journal of Obesity 2016; 40(7): 1089-1095. (DOI: 10.1038/ijo.2016.71)

  5. Lim WH, McDonald SP, Russ GR, Chapman JR, Ma MK, Pleass H, Jaques B, Wong G. Association between delayed graft function and graft loss in donation after cardiac death kidney transplants – a paired kidney registry analysis. Transplantation 2016. (DOI: 10.1097/tp.0000000000001323)

  6. Mahady SE, Wong G, Turner RM, Mitchell P, Macaskill P, Craig JC, George J. Elevated liver enzymes and mortality in older individuals: A prospective cohort study. Journal of Clinical Gastroenterology 2016. (DOI: 10.1097/mcg.0000000000000622)

  7. Miller HM, Tong A, Tunnicliffe DJ, Campbell D, Pinter J, Commons RJ, Athan E, Craig JC, Gilroy N, Green J, Henderson B, Howell M, Stuart RL, van Eps C, Wong MG, de Zoysa J, Jardine MJ. Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International 2016; 21(2), 213-223(DOI: 10.1111/hdi.12457)

  8. Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF. Phosphate-binding agents in adults with CKD: A network meta-analysis of randomized trials. American Journal of Kidney Diseases 2016. (DOI: 10.1053/j.ajkd.2016.05.015)

  9. Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De berardis G, Ruospo M, Natale P. Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruquw L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: A meta-analysis. Journal of the American Medical Association 2016; 316(3): 313-324. (DOI: 10.1001/jama.2016.9400)

  10. Shen K, Johnson DW, Gobe GC. The role of cyclic gmp and its signaling pathways in kidney disease. American Journal of Physiology and Renal Physiology 2016. (DOI: 10.1152/ajprenal.00042.2016)

  11. Wong G, Teixeira-Pinto A, Chapman JR, Craig JC, Pleass H, McDonald S, Lim WH. The impact of total ischaemic time, donor age and the pathway of donor death on graft outcomes after deceased donor kidney transplantation. Transplantation 2016. (DOI: 10.1097/tp.0000000000001351)

  12. Wright D, Gordon R, Carr D, Craig JC, Banks E, Muthayya S, Wutzke S, Eades SJ, Redman S. The study of environment on aboriginal resilience and child health (search): A long-term platform for closing the gap. Public Health Research Practice 2016; 26(3). (DOI: 10.17061/phrp2631635)

August 2016

  1. Chapman JR, Wong G. Cancer in patients with inherited ciliopathies: Polycystic kidney disease. Lancet Oncology 2016. (DOI: 10.1016/s1470-2045(16)30307-2)

  2. Hodson EM, Craig JC. How randomised trials have improved the care of children with kidney disease. Pediatric Nephrology 2016. (DOI: 10.1007/s00467-016-3455-9)

  3. Johnson DW. Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes. Evidence Based Medicine 2016 (DOI: 10.1136/ebmed-2016-110418)

  4. Lim WH, McDonald SP, Kennedy S E, Larkins N, Wong G. Association between slow and delayed graft function with graft outcomes in paediatric and adolescent deceased donor kidney transplant recipients. Transplantation 2016. (DOI: 10.1097/tp.0000000000001464)

  5. Masson P, Kotwal S, Kelly PJ, Craig JC, Lindley RI, Gallagher M.Cass A, Webster AC. Risk factors for stroke in people with end-stage kidney disease: A cohort study. Cerebrovascular Diseases 2016; 42(5-6): 428-438. (DOI: 10.1159/000445067)

  6. Nataatmadja M, Cho Y, Lloyd J, Johnson DW. Aminoglycoside use in patients with chronic kidney disease. In: Kruger E (ed.), Aminoglycosides: Pharmacology, Clinical Uses and Health Effects, Nova Science, New York, 2016.

  7. Nankivell BJ, P’Ng CH, O’Connell PJ, Chapman JR. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: Comparison of cyclosporine and tacrolimus eras. Transplantation 2016; 100(8): 1723-1731. (DOI: 10.1097/tp.0000000000001243)

  8. Norvell DC, Dettori JR, Chapman JR. Enhancing clinical study retention rates to avoid follow-up bias: How do we keep our study participants from “the land of the lost”? Global Spine Journal 2016; 6(5): 519-521. (DOI: 10.1055/s-0036-1584928)

  9. Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P,Crowe S, Van Biesen W, Winkelmayer WC, O’Donoghue D, Tam-Tham H, Shen JI, Pinter J, Larkins N, Youssouf S, Mandayam S, Ju A, Craig JC. Establishing core outcome domains in hemodialysis: Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop. American Journal of Kidney Disease 2016. (DOI: 10.1053/j.ajkd.2016.05.022)

  10. Tong A, Samuel S, Zappitelli M, Dart A, Furth S, Eddy A,Groothoff J, Webb NJ, Yap HK, Bockenhauer D, Sinha A, Alexander SI, Goldstein SL, Gipson DS, Hanson CS, Evangelidis N, Crowe S, Harris T, Hemmelgarn BR, Manns B, Gill J, Tugwell P, VanBiesen W, Wheeler DC, Winkelmayer WC, Craig JC. Standardised outcomes in nephrology-children and adolescents (SONG-kids): A protocol for establishing a core outcome set for children with chronic kidney disease. Trials 2016; 17: 401. (DOI: 10.1186/s13063-016-1528-5)

September 2016

  1. Adams RJ, Appleton S L, Vakulin A, Hanly PJ, McDonald SP, Martin SA, Lang C J, Taylor AW, McEvoy RD, Antic NA, Catcheside PG, Vincent AD, Wittert G A. Association of kidney disease with obstructive sleep apnea in a population study of men. Sleep 2016; Sept 9 pii: sp-00240-16

  2. Badve SV, Palmer SC, Hawley CM, Pascoe EM, Strippoli GF, Johnson DW. Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Journal of Immunology 2016; 31(9), 1425-1436. (DOI: 10.4049/jimmunol.1600990 10.1093/ndt/gfv269)

  3. Campbell DJ, Craig JC, Mudge DW, Brown FG, Wong G, Tong A. Patients’ perspectives on the prevention and treatment of peritonitis in peritoneal dialysis: A semi-structured interview study. Peritoneal Dialysis International 2016; Sept 28 (DOI: 10.3747/pdi.2016.00075)\

  4. Chando S, Young C, Craig JC, Gunasekera H, Tong A. Parental views on otitis media: Systematic review of qualitative studies. European Journal of Pediatrics 2016; 175(10): 1295-1305. (DOI: 10.1007/s00431-016-2779-6)

  5. Chong L, Jamieson N J, Gill D, Singh-Grewal D, Craig JC, Ju A Hanson CS, Tong A. Children’s experiences of epilepsy: A systematic review of qualitative studies. Pediatrics 2016; 138(3). (DOI: 10.1542/peds.2016-0658)

  6. Krishnan  AR, Wong G, Chapman JR, Coates PT, Russ GR, Pleass H, Russell C, He B, Lim, W. H. Prolonged ischemic time, delayed graft function, and graft and patient outcomes in live donor kidney transplant recipients. Am J Transplant 2016; 16(9): 2714-2723. (DOI: 10.1111/ajt.13817)

  7. Liuzzi A R, Kift-Morgan A, Lopez-Anton M, Friberg IM, Zhang J, Brook AC, Roberts GW, Donovan KL, Colmont CS, Toleman MA, Bowen T, Johnson DW, Topley N, Moser B, Fraser DJ, Eberl M. Unconventional human t cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling. Journal of Immunology 2016; 197(6): 2195-2207. (DOI: 10.4049/jimmunol.1600990)

  8. Lopez-Vargas PA, Tong A, Howell M, Craig JC. (2016). Educational interventions for patients with ckd: A systematic review. Am J Kidney Dis, 68(3), 353-370. doi: 10.1053/j.ajkd.2016.01.022

  9. O’Connell P J, Zhang W, Menon M C, Yi Z, Schroppel B, Gallon L, Luan Y, Rosales I A, Ge Y, Losic B, Xi C, Woytovich C, Keung K L, Wei C, Greene I, Overbey J, Bagiella E, Najafian N, Samaniego M, Djamali A, Alexander SI, Nankivell B J, Chapman JR, Smith RN, Colvin R, Murphy B. Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: A multicentre, prospective study. Lancet 2016; 388(10048): 983-993. (DOI: 10.1016/s0140-6736(16)30826-1)

  10. Pinter J, Hanson CS, Craig JC, Chapman JR, Budde K, Halleck F, Tong A. ‘I feel stronger and younger all the time’-perspectives of elderly kidney transplant recipients: Thematic synthesis of qualitative research. Nephrology Dialysis Transplantation 2016; 31(9): 1531-1540. (DOI: 10.1093/ndt/gfv463)

  11. Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, Schick-Makaroff K, Wheeler DC, van Biesen W, Winkelmayer, WC, Johnson DW, Howard K, Evangelidis N, Tong A. Patient and caregiver priorities for outcomes in hemodialysis: An international nominal group technique study. Am J Kidney Disease 2016; 68(3):444-454. (DOI: 10.1053/j.ajkd.2016.02.037)

October 2016

  1. Badve SV, Palmer SC, Strippoli GF, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW. The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: A systematic review and meta-analysis. American Journal of Kidney Disease 2016;68(4): 554-563. (DOI: 10.1007/s00431-016-2779-610.1053/j.ajkd.2016.03.418)

  2. Barraclough KA, Grace BS, Lawton P, McDonald SP. Residential location and kidney transplant outcomes in indigenous compared with nonindigenous Australians. Transplantation 2016; 100(10): 2168-2176. (DOI: 10.1097/tp.0000000000001007)

  3. Chan S, Campbell SB, Clayton PA, Mudge DW, Cho Y, Hawley CM, Johnson DW, Francis RS. Temporal changes in deceased kidney donor characteristics in Australia. Transplantation Direct 2016; 2(11): e112. (DOI: 10.1097/txd.0000000000000624)

  4. Chapman JR, Wong G. Cancer in patients with inherited ciliopathies: Polycystic kidney disease. Lancet Oncology 2016; 17(10): 1343-1345. (DOI: 10.1016/s1470-2045(16)30307-2)

  5. Hodson EM, Wong SC, Willis NS, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Systematic Reviews 2016; 10, Cd003594. (DOI: 10.1002/14651858.CD003594.pub5)

  6. Johnson DW. Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes. Evid Based Med 2016; 21(5): 178. (DOI: 10.1136/ebmed-2016-110418)

  7. Joseph PD, Craig JC, Tong A, Caldwell PH. Researchers’, regulators’, and sponsors’ views on pediatric clinical trials: A multinational study. Pediatrics 2016; 138(4). (DOI: 10.1542/peds.2016-1171)

  8. Kasza J, Wolfe R, McDonald SP, Marshall MR, Polkinghorne KR. Dialysis modality, vascular access and mortality in end-stage kidney disease: A bi-national registry-based cohort study. Nephrology 2016; 21(10): 878-886. (DOI: 10.1111/nep.12688)

  9. Kim S, Lewis JR, Baur LA, Macaskill P, Craig JC. Obesity and hypertension in australian young people: Results from the Australian health survey 2011 to 2012. Internal Medicine Journal 2016;  (DOI: 10.1111/imj.13298)

  10. Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, Del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Schon S, Gargano L, Bots CP, Strippoli GF. Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis. Nephrology Dialysis Transplantation. 2016; 31(10): 1647-1653. (DOI: 10.1053/j.ajkd.2016.03.41810.1093/ndt/gfv413)

  11. Shen K, Johnson DW, Gobe GC. The role of cgmp and its signaling pathways in kidney disease. American Journal of Physiology Renal Physiology. 2016; 311(4): F671-f681. (DOI:10.1152/ajprenal.00042.2016)

  12. Sherriff S, Kalucy D, Fernando P, Hanson CS, Craig JC, Tong A. In their own words: The value of qualitative research to improve the care of children with chronic kidney disease. Journal of Paediatrics and Child Health. 2016. (DOI: 10.1111/jpc.13374)

  13. Young C, Tong A, Gunasekera H, Sheriff S, Kalucy D, Fernando P, Craig JC. Health professional and community perspectives on reducing barriers to accessing specialist health care in metropolitan aboriginal communities: A semi-structured interview study. Journal of Paediatrics and Child Health. 2016; (DOI: 10.1111/jpc.13374)

November 2016

  1. Chan S, Campbell SB, Clayton PA, Mudge DW, Cho Y, Hawley CM, Johnson DW, Francis RS. Temporal changes in deceased kidney donor characteristics in Australia. Transplant Direct 2016; 2(11): e112.  (DOI: 10.1097/txd.0000000000000624)

  2. Chapman JR. Progress in transplantation: Will it be achieved in big steps or by marginal gains? American Journal of Kidney Disease 2016 (DOI: 10.1053/j.ajkd.2016.08.024)

  3. Duffy DL, McDonald SP, Hayhurst B, Panagiotopoulos S, Smith TJ, Wang XL, Wilcken DE, Duarte NL, Mathews J, Hoy WE. Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ace and tp53. BMC Nephrology 2016; 17(1): 183. (DOI: 10.1186/s12882-016-0396-2)

  4. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. Journal of the American Society of Nephrology 2016; 27(11): 3238-3252. (DOI: 10.1681/asn.2016010112)

  5. Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF. Phosphate-binding agents in adults with ckd: A network meta-analysis of randomized trials. American Journal of Kidney Disease. 2016; 68(5): 691-702. (DOI: 10.1053/j.ajkd.2016.05.015)

  6. Ralph AF, Butow P, Hanson CS, Chadban SJ, Chapman JR, Craig JC,  Kanellis J, Luxton G, Tong A. Donor and recipient views on their relationship in living kidney donation: Thematic synthesis of qualitative studies. American Journal of Kidney Disease 2016; (DOI: 10.1053/j.ajkd.2016.09.017)

  7. Wong G, Chakera A, Chapman JR, Chadban SC, Pilmore H, Craig JC, Lim WH. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system? Transplant Infectious Disease. 2016 (DOI: 10.1111/tid.12631)

December 2016

  1. Chapman JR. Message from the editor. Transplantation. 2016 (DOI: 10.1097/tp.0000000000001594)

  2. Didsbury MS, Kim S, Medway MM, Tong A, McTaggart SJ, Walker AM, White S, Mackie FE, Kara T, Craig JC, Wong G. Socio-economic status and quality of life in children with chronic disease: A systematic review. J Paediatr Child Health 2016; 52(12): 1062-1069. (DOI: 10.1111/jpc.13407)

  3. Do Nguyen HT, Wong G, Chapman JR, McDonald SP, Coates PT, Watson N, Russ GR, D’Orsogna L, Lim WH. The association between broad antigen HLA mismatches, Eplet HLA mismatches and acute rejection after kidney transplantation. Transplant Direct 2016; 2(12): e120. (DOI: 10.1097/txd.0000000000000632)

  4. Hodson, EM, Craig JC. How randomised trials have improved the care of children with kidney disease. Pediatr Nephrol 2016; 31(12): 2191-2200.  (DOI: 10.1007/s00467-016-3455-9)

  5. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naiker S,  Pecoits-Filho R, Yu  XQ, Lameire N. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 2016. (DOI: 10.1038/nrneph.2016.181)

  6. Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW. Predictors of residual renal function decline in peritoneal dialysis patients: The balanz trial. Peritoneal Dialalysis International 2016. (DOI: 10.3747/pdi.2016.00206)

  7. Nataatmadja M, Cho Y, Johnson DW. Evidence for biocompatible peritoneal dialysis solutions. Contrib Nephrol 2016, 189, 91-101. (DOI: 10.1159/000450690)

  8. See EJ, Cho Y, Hawley CM, Jaffrey LR, Johnson DW. Early and late patient outcomes in urgent-start peritoneal dialysis. Perit Dial Int 2016. (DOI: 10.3747/pdi.2016.00158)

  9. Wai SN, Kelly JT, Johnson DW, Campbell KL. Dietary patterns and clinical outcomes in chronic kidney disease: The CKD.Qld nutrition study. Journal of Renal Nutrition. 2016 (DOI: 10.1053/j.jrn.2016.10.005)

  10. Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A, Garg AX. Patterns and predictors of screening for breast and cervical cancer in women with ckd. Clin J Am Soc Nephrol 2017; 12(1), 95-104. (DOI: 10.2215/cjn.05990616)

  11. Xu R, Yang Z, Qu Z, Wang H, Tian X, Johnson DW, Dong J. Intraperitoneal vancomycin plus either oral moxifloxacin or intraperitoneal ceftazidime for the treatment of peritoneal dialysis-related peritonitis: A randomized controlled pilot study. Am J Kidney Dis 2016. (DOI: 10.1053/j.ajkd.2016.11.008)

  12. Young C, Gunasekera H, Kong K, Purcell A, Muthayya S, Vincent F, Vincent F, Wright D, Gordon R, Bell J, Gillor G, Booker J, Fernando P, Kalucy D, Sherriff S, Tong A, Parter C, Bailey S, Redman S, Banks E, Craig JC. A case study of enhanced clinical care enabled by aboriginal health research: The hearing, ear health and language services (heals) project. Australian New Zealand Journal of Public Health 2016; 40(6): 523-528.  (DOI: 10.1111/1753-6405.12586)

  13. Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, Liu X, McTaggart S, Morrish AT, Playford G, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW. Representativeness of honeypot trial participants to Australasian PD patients. Peritoneal Dialysis International. 2016. (DOI: 10.3747/pdi.2016.00065)

Socials

Sign up for our Newsletter

Subscribe
I am a
To subscribe to our newsletter, we need to collect personal information from you. This includes your name, email address, and designation. Click yes to consent. Thank you.

Back to Top